lanternpharma.com (LTRN) - Price to Earnings Ratio

Corporate emblem and logo of Lantern Pharma (LTRN)

This daily price chart for Lantern Pharma Inc. (LTRN) with the -0.30 indicator reflects the activity of a business generating revenue through the creation of personalized cancer drugs via AI platforms and partnership payments. Operational stability depends on the availability of high-tech chips and the geopolitical climate in Asia. Meanwhile, the environmental impact remains minimal, as operations are concentrated in cloud services and energy-efficient data centers.

Lantern Pharma (LTRN): Price to Earnings Ratio from 07/04/2022 to 11/15/2026

Comprehensive metric breakdowns and analytics for Lantern Pharma Inc (LTRN)

- share price and expert price forecast:
Price Performance Chart Lantern Pharma Inc.|LTRN - Analyst Consensus Forecast
- market capitalization indicators:
Market Valuation Lantern Pharma Inc|LTRN - Enterprise Value
- balance sheet equity data:
Book Value per Share Lantern Pharma|LTRN - Company Book Value|Capitalization to Book Value Ratio lanternpharma.com|LTRN - Company Total Assets
- debt and solvency information:
Total Debt to Equity Ratio Lantern Pharma Inc.|LTRN - Long-Term Debt to Capital|Current Liabilities to Capital lanternpharma.com|LTRN - Company Debts|Debt to Net Assets Ratio Lantern|LTRN - Company Long-Term Debt|Company Short-Term Debt Lantern Pharma|Quick Ratio lanternpharma.com
- net income and valuation ratios data:
LTRN - Company Net Income|Net Profit Forecast Lantern Pharma Inc.|LTRN - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Lantern Pharma Inc.|LTRN - PEG Multiple|Company Value to EBITDA Lantern|LTRN - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Lantern Pharma|LTRN - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months lanternpharma.com|LTRN - Net earnings per share growth this year|Expected earnings per share trend next year Lantern Pharma Inc.
- sales volume and revenue indicators:
LTRN - Company Revenue|Company Expected Revenue Lantern Pharma Inc.|LTRN - P/S Multiple|Forward Price to Sales Lantern Pharma Inc|LTRN - Sales Growth YoY (TTM)
Comprehensive company analysis:Lantern Pharma Inc - LTRN
Signature product of Lantern Pharma

Lantern Pharma Inc. (LTRN) expansion into the targeted oncology therapy segment via its RADR AI platform requires significant investment, making profit valuation critical. The P/E ratio correlates market capitalization with net income, measuring the cost of one dollar of profit and allowing the company's historical P/E chart to filter out market noise from the business's actual fundamental value.

Analysis of competing companies

AVBP: Company Value to Net Income|P/E Multiple BIAF|Price to Earnings Ratio eEFFECTOR Therapeutics Inc. EFTR